Cardiac phosphoproteome reveals cell signaling events involved in doxorubicin cardiotoxicity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cardiac phosphoproteome reveals cell signaling events involved in doxorubicin cardiotoxicity

Published:2012-08 Issue:15 Volume:75 Page:4705-4716
ISSN:1874-3919
Container-title:Journal of Proteomics
language:en
Short-container-title:Journal of Proteomics

Author:

Gratia Séverine,Kay Laurence,Michelland Sylvie,Sève Michel,Schlattner Uwe,Tokarska-Schlattner Malgorzata

Funder

Marie Curie Intraeuropean Fellowship

Marie Curie European Reintegration Grant

French Agence Nationale de Recherche (“chaire d'excellence” to US)

Publisher

Elsevier BV

Subject

Biochemistry,Biophysics

Reference66 articles.

1. The anthracyclines: will we ever find a better doxorubicin?;Weiss;Semin Oncol,1992

2. Anthracycline-induced cardiotoxicity;Ferreira;Cardiovasc Hematol Agents Med Chem,2008

3. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity;Minotti;Pharmacol Rev,2004

4. Oxidative and non-oxidative mechanisms in the inactivation of cardiac mitochondrial electron transport chain components by doxorubicin;Marcillat;Biochem J,1989

5. Adriamycin cardiomyopathy: pathophysiology and prevention;Singal;FASEB J,1997

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Metabolic Fingerprint of Doxorubicin-Induced Cardiotoxicity in Male CD-1 Mice Fades Away with Time While Autophagy Increases;Pharmaceuticals;2023-11-15

2. Cardiac Molecular Remodeling by Anticancer Drugs: Doxorubicin Affects More Metabolism While Mitoxantrone Impacts More Autophagy in Adult CD-1 Male Mice;Biomolecules;2023-05-31

3. Integrated multi-omics analysis of adverse cardiac remodeling and metabolic inflexibility upon ErbB2 and ERRα deficiency;Communications Biology;2022-09-12

4. Insights on the molecular targets of cardiotoxicity induced by anticancer drugs: A systematic review based on proteomic findings;Metabolism;2022-09

5. Circulating biomarkers for management of cancer therapeutics-related cardiac dysfunction;Cardiovascular Research;2022-05-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3